These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26836374)

  • 1. Diagnosis and management of latent tuberculosis.
    Turetz ML; Ma KC
    Curr Opin Infect Dis; 2016 Apr; 29(2):205-11. PubMed ID: 26836374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in diagnosis and treatment of latent tuberculosis infection.
    Chapman HJ; Lauzardo M
    J Am Board Fam Med; 2014; 27(5):704-12. PubMed ID: 25201941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting latent tuberculosis in compromised patients.
    Sauzullo I; Vullo V; Mastroianni CM
    Curr Opin Infect Dis; 2015 Jun; 28(3):275-82. PubMed ID: 25887610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent tuberculosis infection: Opportunities and challenges.
    Chee CBE; Reves R; Zhang Y; Belknap R
    Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of latent TB infection in areas of high TB prevalence.
    Sharma SK; Mohanan S; Sharma A
    Chest; 2012 Sep; 142(3):761-773. PubMed ID: 22948580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis.
    Chee CB; Sester M; Zhang W; Lange C
    Respirology; 2013 Feb; 18(2):205-16. PubMed ID: 23107218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?
    Banaei N; Gaur RL; Pai M
    J Clin Microbiol; 2016 Apr; 54(4):845-50. PubMed ID: 26763969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Latent Tuberculosis Infection in Children from Developing Countries.
    Jain A; Lodha R
    Indian J Pediatr; 2019 Aug; 86(8):740-745. PubMed ID: 30741387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent tuberculosis infection (LTBI): a real host defence or a permanent threat?
    Sanduzzi A; Ponticiello A; Bocchino M; Perna F; Vatrella A
    Infez Med; 2016 Sep; 24(3):179-82. PubMed ID: 27668896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the management of children with latent tuberculosis infection.
    Venturini E; Tersigni C; Chiappini E; de Martino M; Galli L
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):341-349. PubMed ID: 28074660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.
    Goujon C; Nosbaum A; Bensaid B; Rozières A; Nicolas JF; Bérard F
    Eur J Dermatol; 2012; 22(5):701-2. PubMed ID: 23032063
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
    Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
    Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Latent Tuberculosis Infection.
    Lardizabal AA; Reichman LB
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National position statement for the management of latent tuberculosis infection.
    Stock D;
    Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on latent tuberculosis infection.
    Hartman-Adams H; Clark K; Juckett G
    Am Fam Physician; 2014 Jun; 89(11):889-96. PubMed ID: 25077395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent tuberculosis infection: recent progress and challenges in South Korea.
    Jeon D
    Korean J Intern Med; 2020 Mar; 35(2):269-275. PubMed ID: 32131570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the diagnosis of latent tuberculosis infection.
    Schluger NW
    Semin Respir Crit Care Med; 2013 Feb; 34(1):60-6. PubMed ID: 23460006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.